| GlaxoSmithKline AG - Fluarix Tetra 15 µg / 0.5 ml, Injektionssuspension | | 62961 | | 04 | | Fluarix Tetra 15 µg / 0.5 ml | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 12.07.2017 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derived from A/Singapore/GP1908/2015) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Hong Kong/4801/2014 (H3N2)-like: reassortant virus NYMC X-263B ) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Brisbane/60/2008 (Victoria lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alfa-tocopheroli hydrogenosuccinas, residui: ovalbuminum max. 0.05 µg, formaldehydum max. 5 µg, natrii desoxycholas max. 65 µg, gentamicini sulfas nihil, hydrocortisonum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension injectable | | | | | | Principe actif | Concentr. |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus Stamm A/michigan/45/2015 (H1N1)-Like: Reassortant Virus Ivr-180 Derived from A/singapore/gp1908/2015) | 15 µg | | Haemagglutininum Influenzae a (H3N2) (Virus Stamm A/hong Kong/4801/2014 (H3N2)-Like: Reassortant Virus nymc X-263b ) | 15 µg | | Haemagglutininum Influenzae b (Virus Stamm B/phuket/3073/2013 (Yamagata Lineage)) | 15 µg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Alfa-Tocopheroli Hydrogenosuccinas | | | | Disodium Phosphate Dodecahydrate | | | | Formaldehydum | 5 µg | | | Gentamicini Sulfas Nihil | | | | Haemagglutininum Influenzae b Virus Stamm B/brisbane/60/2008 (Victoria Lineage) | 15 µg | | | Hydrocortisonum Nihil | | | | Potassium Chlorure | | | | Potassium Dihydrogenophosphate | | | | Magnesium Chloride Hexahydrate | | | | Sodium Chlorure | | | | Natrii Desoxycholas | 65 µg | | | Octoxinolum-10 | | | | Ovalbuminum | 0.05 µg | residui | | Polysorbatum 80 | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
